Jugular vein inserted central venous catheters (CVC) and the risk of CVC-related bloodstream infections in patients with hematological malignancies

Am J Hematol. 2022 Sep;97(9):E336-E340. doi: 10.1002/ajh.26633. Epub 2022 Jun 24.

Authors

Enrico Schalk¹, Lena M Biehl^{2

3}, Boris Böll^{2

4}

Affiliations

¹ Otto-von-Guericke University Magdeburg, Medical Center, Department of Hematology and Oncology, Magdeburg, Germany.
² Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
³ German Centre for Infection Research, Bonn-Cologne, Germany.
⁴ Center for Integrated Oncology (CIO), Aachen, Bonn, Cologne, Düsseldorf (ABCD), Cologne, Germany.

PMID: 35713556
DOI: 10.1002/ajh.26633

No abstract available

Publication types

Letter

MeSH terms

Catheterization, Central Venous* / adverse effects
Central Venous Catheters* / adverse effects
Hematologic Neoplasms* / complications
Hematologic Neoplasms* / therapy
Humans
Jugular Veins
Sepsis*

Associated data

DRKS/DRKS00006551